Avaxim  VACCINE FOR HEPATITIS A 160 mcg

Avaxim  VACCINE FOR HEPATITIS A 160 mcg
€ 49.00
Add to Cart
This medicine is a vaccine in the form of an injectable suspension / 0,5 ml pre-filled syringe with or without needle in boxes of 1 /
This vaccine has been shown to protect against infection caused by the hepatitis A virus in adolescents aged 16 and older.

Avaxim  VACCINE FOR HEPATITIS A 160 mcg

 
 
WHAT IS Avaxim  160U AND WHAT IT IS USED FOR?
This medicine is a vaccine in the form of an injectable suspension / 0,5 ml pre-filled syringe with or without needle in boxes of 1 /
This vaccine has been shown to protect against infection caused by the hepatitis A virus in adolescents aged 16 and older.
This vaccine will not protect against infections caused by other types of hepatitis viruses or other known pathogens affecting the liver.

Before using Avaxim  160U
Do not use Avaxim  160U:
- In the case of fever, acute disease exacerbated chronic disease
- In the case of allergy to any component of the vaccine
 
Take precautions when using Avaxim  160U:
- Do not inject intravascularly
- This vaccine should not be administered in the gluteal region or intradermally
- Immune response to the vaccine may be reduced in patients on immunosuppressive therapy or in a state of immune deficiency.
- Vaccine may have no effect on the development of hepatitis A, if applied during the incubation period of the disease.
- In people with liver disease
- In people who are allergic to neomycin

Pregnancy and lactation
As a precaution, it is preferable that the vaccine should not be administered during pregnancy except at high risk of infection.
 
HOW TO USE Avaxim  160U?
The recommended dose for persons aged 16 and over was 0.5 ml.
Primary protection is obtained after a single injection.
To obtain a long-term protection in a second dose to be administered is preferably between 6 and 12 months after the first vaccination and up to 36 months after.

AND METHOD OF APPLICATION:
It is recommended that this vaccine can be administered intramuscularly to minimize local effects. The recommended injection site is the deltoid muscle.
Do not inject intravascularly: check that the needle does not penetrate the blood vessel.
The vaccine should not be injected in the gluteal region or intradermally.
Exceptionally, the vaccine may be administered subcutaneously in patients suffering from thrombocytopenia or in patients at risk of bleeding.
The vaccine must not be mixed with other vaccines in the same syringe.
Shake before injection until a homogeneous suspension.
 
POSSIBLE SIDE EFFECTS?
- Pain at the injection site, at times accompanied by redness. Very rarely occurs sealing injection site.
- Slight fever, fatigue, headache, muscle and joint aches and pains from the camp of the gastrointestinal tract.
- In rare cases established mild reversible elevations in liver enzymes.
- Exceptionally observed skin reactions such as itching, rash, urticaria.
 
 
€ 49.00
Add to Cart
Close